Callan Family Office LLC Makes New $2.45 Million Investment in Axon Enterprise, Inc $AXON

Key Points

• Callan Family Office LLC has made a new investment of $2.45 million in Axon Enterprise, acquiring 2,964 shares during the second quarter.
• Axon Enterprise has seen significant interest from institutional investors, with hedge funds like Jennison Associates LLC increasing their holdings by over 23,000% recently.
• Wall Street analysts have mixed ratings on Axon, with 14 analysts rated it as a "Buy" while 4 rated it as "Hold," indicating a strong overall consensus on its stock performance.

Callan Family Office LLC purchased a new stake in Axon Enterprise, Inc (NASDAQ:AXON - Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 2,964 shares of the biotechnology company's stock, valued at approximately $2,454,000.

Other hedge funds have also recently modified their holdings of the company. Jennison Associates LLC increased its holdings in Axon Enterprise by 23,203.7% during the first quarter. Jennison Associates LLC now owns 614,053 shares of the biotechnology company's stock valued at $322,961,000 after buying an additional 611,418 shares during the period. Nuveen LLC bought a new stake in Axon Enterprise during the 1st quarter valued at $264,796,000. McElhenny Sheffield Capital Management LLC purchased a new position in shares of Axon Enterprise in the 2nd quarter valued at $255,833,000. Westfield Capital Management Co. LP raised its position in shares of Axon Enterprise by 29.8% in the 1st quarter. Westfield Capital Management Co. LP now owns 927,801 shares of the biotechnology company's stock worth $487,977,000 after acquiring an additional 212,931 shares in the last quarter. Finally, Vanguard Group Inc. raised its position in shares of Axon Enterprise by 2.2% in the 1st quarter. Vanguard Group Inc. now owns 8,632,008 shares of the biotechnology company's stock worth $4,540,005,000 after acquiring an additional 185,571 shares in the last quarter. Hedge funds and other institutional investors own 79.08% of the company's stock.

Wall Street Analyst Weigh In

AXON has been the topic of a number of recent research reports. Zacks Research downgraded Axon Enterprise from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, September 2nd. Craig Hallum upgraded shares of Axon Enterprise from a "hold" rating to a "buy" rating and set a $900.00 price target on the stock in a report on Tuesday, August 5th. Piper Sandler started coverage on shares of Axon Enterprise in a research note on Tuesday, September 23rd. They set an "overweight" rating and a $893.00 price objective for the company. Needham & Company LLC restated a "buy" rating and issued a $870.00 target price on shares of Axon Enterprise in a research note on Wednesday, September 24th. Finally, UBS Group reaffirmed a "neutral" rating and issued a $840.00 price target (up from $820.00) on shares of Axon Enterprise in a report on Tuesday, August 5th. Fourteen research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company's stock. According to MarketBeat, Axon Enterprise has an average rating of "Moderate Buy" and a consensus price target of $841.64.

Insiders Place Their Bets

In other Axon Enterprise news, Director Hadi Partovi purchased 1,358 shares of the business's stock in a transaction that occurred on Wednesday, August 13th. The shares were bought at an average price of $740.00 per share, for a total transaction of $1,004,920.00. Following the acquisition, the director owned 237,938 shares in the company, valued at $176,074,120. This represents a 0.57% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CFO Brittany Bagley sold 5,000 shares of Axon Enterprise stock in a transaction that occurred on Monday, September 29th. The shares were sold at an average price of $713.88, for a total transaction of $3,569,400.00. Following the sale, the chief financial officer owned 93,592 shares of the company's stock, valued at approximately $66,813,456.96. The trade was a 5.07% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 59,932 shares of company stock valued at $45,115,616. Insiders own 4.40% of the company's stock.

Axon Enterprise Trading Down 4.2%

Shares of Axon Enterprise stock opened at $703.03 on Friday. The firm's 50 day simple moving average is $755.57 and its two-hundred day simple moving average is $713.70. The firm has a market capitalization of $55.19 billion, a price-to-earnings ratio of 173.59, a PEG ratio of 27.30 and a beta of 1.41. Axon Enterprise, Inc has a 12-month low of $422.38 and a 12-month high of $885.91. The company has a current ratio of 2.95, a quick ratio of 2.71 and a debt-to-equity ratio of 0.63.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last posted its quarterly earnings data on Monday, August 4th. The biotechnology company reported $2.12 EPS for the quarter, topping the consensus estimate of $1.54 by $0.58. Axon Enterprise had a net margin of 13.64% and a return on equity of 6.80%. The business had revenue of $668.54 million during the quarter, compared to the consensus estimate of $641.77 million. During the same period in the previous year, the firm posted $1.20 earnings per share. The business's revenue for the quarter was up 32.6% compared to the same quarter last year. Axon Enterprise has set its FY 2025 guidance at EPS. Analysts predict that Axon Enterprise, Inc will post 5.8 EPS for the current year.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.